Get short, timely messages from BioCentury.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @BioCentury.

Get updates via SMS by texting follow BioCentury to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

BioCentury

  1. Senator seeks to extend therapeutic tax credit biocentury.com/dailynews/poli…
  2. ODAC meeting to discuss RCC imaging biocentury.com/dailynews/poli…
  3. House to vote on PDUFA bill next week biocentury.com/dailynews/poli…
  4. CIRM awards $69 million in grants biocentury.com/dailynews/poli…
  5. HOLIDAY NOTICE biocentury.com/dailynews/fina…
  6. Delcath raises $20 million biocentury.com/dailynews/fina…
  7. EMA committee backs approval of Kalydeco biocentury.com/dailynews/comp…
  8. Chugai seeks Japanese approval for pertuzumab biocentury.com/dailynews/comp…
  9. CHMP recommends perampanel, aclidinium bromide biocentury.com/dailynews/comp…
  10. Pradaxa benefits outweigh bleeding risk biocentury.com/dailynews/comp…
  11. MediciNova falls on asthma data biocentury.com/dailynews/clin…
  12. Senate passes amended PDUFA bill biocentury.com/dailynews/tops…
  13. Sangart adds $50 million biocentury.com/dailynews/fina…
  14. Life sciences visits the ATM biocentury.com/dailynews/fina…
  15. Device company Flowonix raises $25 million biocentury.com/dailynews/fina…
  16. Delcath proposes follow-on biocentury.com/dailynews/fina…
  17. Teva cuts guidance as Levin prepares new strategy biocentury.com/dailynews/comp…
  18. IMI launches antibiotic research program biocentury.com/dailynews/comp…
  19. FDA panel backs accelerated approval for Tafamidis biocentury.com/dailynews/comp…
  20. D-Pharm, Thrombotech to merge biocentury.com/dailynews/comp…